Magnesium Deficiency Linked to Poorer Diabetes Control; Supplementation May Improve Insulin Sensitivity
Maintaining adequate mineral levels may be a critical factor in managing type 2 diabetes. According to research, magnesium deficiency can potentially worsen serious complications associated with diabetes, while supplementation has shown the ability to improve metabolic control.
A clinical randomized double-blind placebo-controlled trial focused on 63 subjects with type 2 diabetes who presented with decreased serum magnesium levels (0.74 mmol/l or lower). All participants in the study were being treated with glibenclamide. To determine the impact of the mineral on health outcomes, researchers administered a daily 50 ml magnesium chloride (MgCl2) solution—containing 50 g of MgCl2 per 1,000 ml—to one group, while another received a placebo over a 16-week period.
The results indicated that oral magnesium supplementation significantly restored serum magnesium levels, which in turn improved both insulin sensitivity and overall metabolic control. By the end of the study, the magnesium group showed a serum magnesium concentration of 0.74 +/- 0.10 mmol/l, compared to 0.65 +/- 0.07 mmol/l in the control group.
Key metabolic improvements were observed in the supplemented group, including:
- Lower Fasting Glucose: Levels dropped to 8.0 +/- 2.4 mmol/l, compared to 10.3 +/- 2.1 mmol/l in the placebo group.
- Reduced HbA(1c): The magnesium group recorded 8.0 +/- 2.4%, while the control group remained higher at 10.1 +/- 3.3%.
- Improved Insulin Sensitivity: The Homeostasis model assessment for insulin resistance (HOMA-IR) index was significantly lower in the magnesium group (3.8 +/- 1.1) than in the control group (5.0 +/- 1.3).
These findings highlight the importance of mineral balance in treating metabolic diseases, as stabilizing blood glucose and improving insulin response can reduce the long-term risks associated with diabetes. Supporting research further suggests that magnesium may help by upregulating the insulin receptor and glucose transporter-4, a mechanism observed in studies involving diabetic rats.
Beyond diabetes management, magnesium is recognized for its fundamental role in cardiovascular protection and bone health. We see also sometimes utilized as a supplement to address fatigue, irregular sleep, and loss of appetite.
To ensure the accuracy of the clinical trial, researchers established strict exclusion criteria. Individuals with reduced renal function, alcoholism, chronic diarrhea, or those using calcium antagonist drugs and diuretics were excluded from the study.
